- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Castration-sensitive Prostate Cancer in New Zealand
Total 2038 results
-
Stony Brook UniversityThe University of Texas Health Science Center at San AntonioRecruitingMetastatic Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastasis | Spine Metastases | Metastatic Tumor | Metastatic Tumor of Bone | Metastatic Tumor to the SpineUnited States
-
Cota Inc.Blue Cross Blue Shield; NantHealth Inc.TerminatedPancreatic Cancer | Metastatic Lung Cancer | Metastatic Breast Cancer | Metastatic Melanoma | Metastatic Prostate Cancer | Metastatic Colon CancerUnited States
-
Carolina Research Professionals, LLCAstellas Pharma IncCompletedProstate Carcinoma Metastatic to the BoneUnited States
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaboratorsRecruitingProstate Cancer | Radiotherapy Side EffectDenmark
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Bristol-Myers SquibbCompletedNeoplasm Metastasis | Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Hormone-refractory Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCapcureCompletedCancer | ProstateUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingSolid Tumor | Metastatic Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Solid Carcinoma | Metastatic TumorUnited States
-
BayerCompletedBone Metastases | Hormone Refractory Prostate CancerItaly, Spain, Hong Kong, Canada, United Kingdom, France, Australia, United States, Germany, Brazil, Israel, Netherlands, Norway, Belgium, Sweden, Czech Republic, Poland, Singapore, Slovakia
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
Cougar Biotechnology, Inc.CompletedProstate Cancer | Prostate NeoplasmsUnited States
-
Memorial Sloan Kettering Cancer CenterNo longer availableRecurrent Prostate Cancer | Prostate CancerUnited States
-
Ardeshir RastinehadPhilips HealthcareRecruitingProstate Cancer | Prostate Disease | Elevated Prostate Specific Antigen | Family History of Prostate Cancer | Positive Digital Rectal ExamUnited States
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate CancerUnited States
-
Trans Tasman Radiation Oncology GroupAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Urological...Active, not recruiting
-
Weill Medical College of Cornell UniversityCompletedProstate CancerUnited States
-
CellCentric Ltd.RecruitingAdvanced Solid Tumors | Metastatic Breast Cancer | Non-small Cell Lung Cancer | Metastatic Castration-Resistant Prostate CancerUnited Kingdom, United States, Netherlands, France, Spain, Sweden
-
Tyme, IncCompletedProstate Cancer | Rising Prostate Specific Antigen (PSA)United States
-
Xencor, Inc.ICON plcRecruitingOvarian Cancer | Endometrial Cancer | Cervical Carcinoma | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Clear Cell CarcinomaUnited States
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
Carolina Research Professionals, LLCBayerCompleted
-
Merrion Pharmaceuticals, LLCCompletedHormone-Refractory Prostate CancerUnited States, Estonia, Latvia
-
CS Diagnostics GmbHAix ScientificsTerminatedProstate Cancer Patients Treated by RadiotherapyGermany
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount SinaiActive, not recruitingLow Risk Prostate CancerUnited States
-
Dana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Precision Biopsy, Inc.UnknownCellular Diagnosis, Prostate CancerUnited States
-
Precision Biopsy, Inc.UnknownCellular Diagnosis, Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
University of Medicine and Dentistry of New JerseyUnited States Department of DefenseWithdrawnProstate CancerUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States, Russian Federation
-
ProteoMediX AGCompletedIndication for Prostate Biopsy Due to Suspected Prostate CancerAustria, Germany, Denmark
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer... and other conditionsUnited States
-
Eli Lilly and CompanyCompleted
-
Ashutosh Kumar TewariOncovir, Inc.RecruitingProstate Cancer Patients on Active SurveillanceUnited States
-
Catherine SpinaArcus Biosciences, Inc.RecruitingOligometastatic Prostate CancerUnited States
-
SpectraCure ABRecruitingRecurrent Prostate CancerUnited States, Canada, United Kingdom, Sweden
-
Genta IncorporatedUnknownProstate CancerUnited States
-
Oxford BioMedicaMedSource LLCTerminatedHormone Refractory Prostate CancerUnited States
-
RPCR, Inc.UnknownProstate Cancer Early Risk Treated by Radiosurgery | Prostate Cancer Intermediate Risk Treated by RadiosurgeryUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminated
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
Trans Tasman Radiation Oncology GroupBayer; Peter MacCallum Cancer Centre, AustraliaRecruitingAdvanced Prostate Carcinoma | Castrate Resistant Prostate Cancer | Cancer of Prostate | PSAAustralia, Singapore
-
Janssen Research & Development, LLCWithdrawn
-
Sapience TherapeuticsRecruitingBreast Cancer | Glioblastoma | Prostate Cancer | Brain Cancer | Glioblastoma Multiforme | GBM | Metastatic Breast Cancer | Recurrent Glioblastoma | Metastatic Melanoma | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Newly Diagnosed Glioblastoma | Melanoma Stage IV | Melanoma RecurrentUnited States, United Kingdom
-
Effector TherapeuticsCompletedCastrate-resistant Prostate Cancer (CRPC)United States
-
Philips HealthcareWithdrawnProstate CancerUnited States